GSK – HIV

// services
Experiential Design
Brand Identity
Motion Design
WebAR prototype Solarflare built with Radley Yeldar for GSK, turning HIV molecular imagery into an explorable AR experience accessible on any phone, no app needed.
Making molecular science accessible
GSK's HIV research programme produces imagery that is scientifically precise and visually extraordinary, but it exists almost entirely within specialist contexts. Working with Radley Yeldar, we built a WebAR prototype that takes GSK's HIV molecular visualisations and puts them in the hands of anyone with a phone, with no app download and no scientific background required. The goal was accessibility: making the complexity available to people who are not trained to read it.Science communication to non-specialist audiences is a design problem as much as a content problem. The AR environment strips away the clinical framing that usually surrounds molecular imagery and replaces it with something more like discovery. The user is not reading about HIV; they are holding a model of it, rotating it, getting close to it. That physical relationship changes what the information feels like.
WebAR as the right delivery format
Choosing WebAR for a healthcare communications prototype was deliberate. The alternative, a native app, introduces friction at every stage of a use case that depends on accessibility. A patient advocate who wants to show a molecular model to a community group does not want to ask everyone to download an application. A journalist covering HIV research for a general audience wants to link to something, not to an app store page.Browser-based AR keeps the barrier low enough that the content can travel. We built the prototype with that distribution model in mind, ensuring that the AR scenes loaded cleanly across a wide range of Android and iOS browsers and that the interaction required no prior technical knowledge to complete.
Prototype as proof of concept
This was delivered as a prototype, which shaped every decision about scope and technical approach. The goal was to demonstrate what was possible and to give GSK and Radley Yeldar a working reference for the next phase of the programme.The molecular visualisations required close collaboration with the GSK science team to ensure accuracy. Scientific communication only works if the science is right, and WebAR that misrepresents molecular structure, however accessible it is, does more harm than good. We built review loops with the science team into the production schedule and treated their corrections as design constraints rather than last-minute changes.